Merck Millipore Hosts Two Chromatography User Group Meetings

• 9th Annual ProSep^® User Group Meeting to be held November 13-14
• 1st Annual Ion Exchange User Group Meeting to be held November 15-16

November 13, 2012, Darmstadt, Germany — Merck Millipore, the Life Science division of Merck, today announced two upcoming chromatography user group meetings that will be held at The Fairmont San Francisco in California. The 9th Annual ProSep^® User Group Meeting will occur November 13-14, followed by the 1st Annual Ion Exchange User Group Meeting on November 15-16.

User Group Meetings attract global biotechnology and biopharmaceutical industry professionals, including those in chromatography R&D, process development, production management and engineering. This year marks Merck Millipore’s ninth ProSep^® User Group Meeting, and for the first time, the company will also be hosting a similar meeting for ion exchange chromatography users. These technical forums allow end users to share lessons learned and best practices, as well as identify existing challenges and discuss trends and future needs.

The 9th Annual ProSep^® User Group Meeting will be chaired by Bioprocess Consultant Gregory Blank, Ph.D. The meeting will include topics such as:

• Method development case studies
• High throughput screening
• Cycling studies
• Viral clearance studies
• Secondary wash optimization
• Cleaning and sanitization strategies
• Optimized resin column packing.

For more information on the ProSep^® User Group meeting please visit www.merckmillipore.com/ProSepusergroup.

The 1st Annual Ion Exchange User Group Meeting will be led by John Moscariello, Ph.D., Principal Scientist at Amgen, Inc. Subjects to be discussed include:

• Process development case studies
• High throughput screening
• Improving recovery from mixed-mode resins
• Cleaning and sanitization strategies
• Raw material characterization
• Optimized resin column packing

For more information on the Ion Exchange User Group meeting please visit www.merckmillipore.com/iexusergroup.  

About Merck Millipore
Merck Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers’ success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, Merck Millipore serves as a strategic partner to customers and helps advance the promise of life science.

Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 67 countries and 2011 revenues of EUR 2.4 billion. Merck Millipore operates as EMD Millipore in the U.S. and Canada.

Note: Merck KGaA or Merck shall mean Merck KGaA, Darmstadt, Germany